Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Serial Interferon Gamma Release Assay in Latent Tuberculosis Infection (CROSBI ID 156250)

Prilog u časopisu | stručni rad

Dodig, Slavica ; Zrinski Topić, Renata Serial Interferon Gamma Release Assay in Latent Tuberculosis Infection // Laboratory medicine, 40 (2009), 11; 681-682. doi: 10.1309/LMJ62BPKL7AKRVYJ

Podaci o odgovornosti

Dodig, Slavica ; Zrinski Topić, Renata

engleski

Serial Interferon Gamma Release Assay in Latent Tuberculosis Infection

The aim of this report is to present results of serial interferon-gamma (IFN-γ ) determination (QuantiFERON-TB Gold In-Tube assay) in a 57-year-old BCG-vaccinated female health care worker with a latent tuberculosis infection. Increased IFN-γ , IgA, and anti-thyroglobulin (anti-Tg) autoantibodies were recorded throughout a 13-month follow-up. After 13 months the subject was clinically healthy and free from any signs and symptoms of active tuberculosis. The increased levels of anti-Tg autoantibodies may have been a concurrent process that did not impair the patient’s immune status. Since false-positive IgA could be found in patients suffering from autoimmune thyroid diseases, it could be assumed increased IgA in this subject is a result of the positive interferences of goat anti-IgA antibodies. Although isoniazid prophylaxis was not used, tuberculosis did not develop during the follow-up period. Serial determination of IFN-γ is necessary due to occupational exposure to tubercle bacilli.

IgA; IFN-gamma; latent tuberculosis infection; thyroid autoantibody

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

40 (11)

2009.

681-682

objavljeno

0007-5027

10.1309/LMJ62BPKL7AKRVYJ

Povezanost rada

Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita, Farmacija

Poveznice
Indeksiranost